| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |